Ftse Mib
33.746,66
-1,60%
DAX
17.932,17
-1,10%
S&P 500
5.035,69
-1,57%
NASDAQ Composite
15.657,82
-2,04%
Bitcoin
57.518,05
-5,09%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Femasys Inc (FEMY) Femasys Inc (FEMY) Notizie

Femasys Inc

FEMY
1,27
0,00 (0,00%)
01 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
18/4/202414:30GLOBEFemasys CEO and Founder Kathy Lee-Sepsick Meets with Members..
28/3/202421:05GLOBEFemasys Announces Financial Results for Year Ended December..
21/3/202414:00GLOBEFemasys Invites Investors to View Fireside Chat Today, March..
20/3/202413:15GLOBEFemasys Announces Positive Topline Data from Pivotal Trial..
13/3/202414:00GLOBEFemasys to Participate in Fireside Chat to Discuss the..
06/3/202415:09EDGAR2Form 8-K - Current report
06/3/202415:00GLOBEFemasys Completes the First In-Office Commercial Procedure..
28/2/202415:16EDGAR2Form 8-K - Current report
14/2/202403:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202403:44EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/2/202414:47EDGAR2Form 8-K - Current report
02/2/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
08/12/202315:28EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
30/11/202323:17EDGAR2Form S-3 - Registration statement under Securities Act of..
29/11/202322:05EDGAR2Form 8-K - Current report
22/11/202322:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202322:33EDGAR2Form 3 - Initial statement of beneficial ownership of..
21/11/202323:30EDGAR2Form 8-K - Current report
15/11/202323:19EDGAR2Form 8-K - Current report
15/11/202314:30BWPharmaCyte Biotech Acquires $5 Million Stake in Emerging..
02/11/202302:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202314:01EDGAR2Form 8-K - Current report
03/10/202315:28EDGAR2Form 8-K - Current report
03/10/202315:27EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
27/9/202314:19EDGAR2Form 8-K - Current report
06/9/202323:00EDGAR2Form 8-K - Current report
10/8/202314:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202314:05EDGAR2Form 8-K - Current report
07/8/202314:40EDGAR2Form DEF 14A - Other definitive proxy statements
03/8/202315:04EDGAR2Form 8-K - Current report
28/7/202323:15EDGAR2Form PRE 14A - Other preliminary proxy statements
27/7/202315:04EDGAR2Form 8-K - Current report
14/7/202322:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
07/7/202322:26EDGAR2Form S-1/A - General form for registration of securities..
04/7/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/7/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: Min: Max:
Chiusura: 1,27

La tua Cronologia

NASDAQ
FEMY
Femasys
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network